Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?

Ömer Uludağ Suzan Cinar Thomas C R McDonnell Erhan Çene Yasemin Yalcinkaya Ahmet Gül Murat Inanç Bahar Artim Esen

Published in: Turkish journal of medical sciences (2023)

Both the GAPSS and aGAPSS successfully predict the thrombotic risk in aPL (+) patients and aCL IgA, aβ2GPI IgA, and aDI IgG do not contribute to high a GAPSS or aGAPSS.

Keyphrases

risk assessment
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
heavy metals
climate change
patient reported outcomes